Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,390 | -14,280 | -16,560 | -14,640 | -14,290 |
| Depreciation Amortization | 60 | 210 | 380 | 930 | 920 |
| Other Working Capital | -1,660 | -530 | 1,680 | 490 | 810 |
| Other Operating Activity | 3,480 | 460 | 70 | 520 | 410 |
| Operating Cash Flow | $-17,510 | $-14,140 | $-14,430 | $-12,700 | $-12,150 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -8 | -100 | -80 | -30 |
| Other Investing Activity | -1,930 | 3,658 | 11,930 | 4,450 | 11,920 |
| Investing Cash Flow | $-2,000 | $3,650 | $11,830 | $4,370 | $11,890 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 26,490 | 32,610 | 3,260 | 11,330 | 240 |
| Financing Cash Flow | $26,490 | $32,610 | $3,260 | $11,330 | $240 |
| Exchange Rate Effect | -330 | -110 | 0 | 0 | 0 |
| Beginning Cash Position | 31,500 | 6,540 | 6,330 | 3,260 | 3,510 |
| End Cash Position | 38,150 | 28,560 | 7,010 | 6,280 | 3,490 |
| Net Cash Flow | $6,640 | $22,020 | $670 | $3,010 | $-20 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,510 | -14,140 | -14,430 | -12,700 | -12,150 |
| Free Cash Flow | -17,510 | -14,140 | -14,430 | -12,700 | -12,150 |